Alejandra C. López Fuentes

Learn More
Peripheral T-cell lymphomas (PTCL) are rare but markedly aggressive forms of non-Hodgkin's lymphoma (NHL). They carry a poor prognosis, with current therapeutic approach being generally ineffective. The most employed first-line treatment is CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), which still results in high rates of relapses.(More)
The amount of scientific papers in the Molecular Biology field has experienced an enormous growth in the last years, prompting the need of developing automatic Information Extraction (IE) systems. This work is a first step towards the ontology-based domain-independent generalization of a system that identifies Escherichia coli regulatory networks. First, a(More)
The number of cancer survivors is estimated by 2022 to increase to almost 18 million, in part because of improvements in earlier detection and cancer therapies, leading to longer-term survival of cancer patients. This growing number of survivors has presented challenges to the healthcare community, one of which is the need to provide to the survivor a(More)
  • 1